Work

P54 VISIBLE cohort B: guselkumab demonstrates significant scalp clearance at Week 16 in participants with moderate-to-severe scalp psoriasis across all skin tones

Year: 2024

Type: conference-abstract

Source: British Journal of Dermatology

DOI: 10.1093/bjd/ljae360.084

Language: English

Topic: Psoriasis: Treatment and Pathogenesis

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4405230515

Cites:

Cited by:

Related to: 10